LQDA
Liquidia Corporation
NASDAQ · Healthcare · Biotechnology · US
$68.66
+0.04%0
Insider buys (3m)
73
Insider sells (3m)
-$138.6M
Net value (3m)
+11.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Krepp Sarah · officer: Chief Human Resource Officer | Sale | 274 | $68 |
| Aug 25, 2026 | Adair Jason · officer: Chief Business Officer | M-Exempt | 9,000 | $9.31 |
| Aug 25, 2026 | Adair Jason · officer: Chief Business Officer | M-Exempt | 10,762 | $14 |
| Aug 25, 2026 | Adair Jason · officer: Chief Business Officer | Sale | 31,799 | $69 |
| Aug 25, 2026 | Adair Jason · officer: Chief Business Officer | Sale | 41,832 | $69 |
| Aug 25, 2026 | Adair Jason · officer: Chief Business Officer | M-Exempt | 11,799 | $9.31 |
| Aug 25, 2026 | Adair Jason · officer: Chief Business Officer | M-Exempt | 238 | $14 |
| Aug 21, 2026 | Rielly-Gauvin Katherine · director | Sale | 18,393 | $72 |
| Aug 21, 2026 | Rielly-Gauvin Katherine · director | M-Exempt | 23,455 | $2.51 |
| Aug 21, 2026 | Rielly-Gauvin Katherine · director | Sale | 36,789 | $75 |
| Aug 21, 2026 | Rielly-Gauvin Katherine · director | M-Exempt | 11,727 | $2.51 |
| Aug 21, 2026 | Rielly-Gauvin Katherine · director | M-Exempt | 13,334 | $2.59 |
| Aug 21, 2026 | Rielly-Gauvin Katherine · director | M-Exempt | 6,666 | $2.59 |
| Aug 19, 2026 | Saggar Rajeev · officer: Chief Medical Officer | Sale | 29,534 | $77 |
| Aug 19, 2026 | Saggar Rajeev · officer: Chief Medical Officer | M-Exempt | 50,000 | $3.73 |
| Aug 19, 2026 | Saggar Rajeev · officer: Chief Medical Officer | Sale | 50,000 | $74 |
| Jul 29, 2026 | Adair Jason · officer: Chief Business Officer | Sale | 688 | $88 |
| Jul 29, 2026 | Boyle Dana · officer: Chief Accounting Officer | Sale | 1,600 | $88 |
| Jul 24, 2026 | Bloch Stephen M · director | Sale | 14,562 | $89 |
| Jul 24, 2026 | Bloch Stephen M · director | Sale | 37,406 | $88 |
| Jul 24, 2026 | Bloch Stephen M · director | Sale | 3,600 | $91 |
| Jul 24, 2026 | Bloch Stephen M · director | Sale | 96,400 | $89 |
| Jul 24, 2026 | Bloch Stephen M · director | Sale | 48,032 | $89 |
| Jul 22, 2026 | Bloch Stephen M · director | Sale | 556 | $81 |
| Jul 22, 2026 | Bloch Stephen M · director | Sale | 3,596 | $80 |
| Jul 22, 2026 | Bloch Stephen M · director | Sale | 74,444 | $80 |
| Jul 14, 2026 | Boyle Dana · officer: Chief Accounting Officer | Sale | 641 | $71 |
| Jul 14, 2026 | Khindri Sanjeev · officer: Chief Development Officer | Sale | 84 | $71 |
| Jul 14, 2026 | Adair Jason · officer: Chief Business Officer | M-Exempt | 3,869 | $0.00 |
| Jul 14, 2026 | Adair Jason · officer: Chief Business Officer | Sale | 562 | $71 |
Institutional positioning
13F filings over the trailing two quarters
New 187Increased 183Reduced 168Sold out 37
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 10,788,586 | Aug 7, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Unchanged | 8,656,038 | May 15, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 8,365,038 | Aug 14, 2026 |
| CALIGAN PARTNERS LP | Unchanged | 8,118,892 | May 15, 2026 |
| Caligan Partners LP | Unchanged | 8,118,892 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 5,489,144 | May 13, 2026 |
| FINDELL CAPITAL MANAGEMENT LLC | Increased | 4,802,212 | Aug 14, 2026 |
| FINDELL CAPITAL MANAGEMENT LLC | Reduced | 3,552,112 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,139,183 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 3,030,395 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,926,945 | May 15, 2026 |
| OPALEYE MANAGEMENT INC. | Reduced | 2,545,000 | May 15, 2026 |
| Opaleye Management Inc. | Reduced | 2,447,500 | Aug 14, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 2,287,792 | May 18, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 2,121,290 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026